Stockreport

AbbVie (ABBV) to Buy Landos to Strengthen Autoimmune Portfolio [Yahoo! Finance]

AbbVie Inc.  (ABBV) 
Last abbvie inc. earnings: 5/1 07:43 am Check Earnings Report
US:NYSE Investor Relations: investors.abbvie.com/investor-overview
PDF The acquisition, if successfully closed, will add Landos' lead pipeline candidate, NX-13, which is a first-in-class, oral NLRX1 agonist in phase II development for the [Read more]